July 23, 2019
Takeda Pharmaceutical said on July 22 that Shire Japan, now under its aegis, has submitted a new drug application in Japan for its von Willebrand disease (VWD) treatment vonicog alfa, otherwise known as Vonvendi overseas. VWD is a blood disorder...read more